Cancer

HIFU Prostate Services Announces Acquisition of Vituro Health

Combination of Leading Mobile HIFU Providers Benefits the Physicians and Hospitals CHARLOTTE, NC / ACCESSWIRE / April 16, 2024 /…

3 months ago

Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care

Jaguar planning to begin commercial launch in Q3 2024 for Gelclair®, the company's third prescription productOral mucositis, also called "chemo…

3 months ago

CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines

Agreement creates strong synergies between CureVac's unique end-to-end mRNA capabilities and MD Anderson's translational and clinical research expertiseCollaboration aims to…

3 months ago

Lender Requests to Convert Loan to MindBio Shares

VANCOUVER, BC / ACCESSWIRE / April 16, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio") is pleased to…

3 months ago

RSNA and GE HealthCare Bring Advanced Mammography Technology to Tanzania to Improve Access and Help Address Breast Cancer Mortality Rate

Radiologists at Muhimbili National Hospital, part of the Muhimbili University of Health and Sciences and the largest public hospital in…

3 months ago

Healing Realty Trust Appoints Three Advisory Board Members Across Strategic Sectors

Jupiter, Florida--(Newsfile Corp. - April 16, 2024) - Healing Realty Trust ("HRT" or the "Company"), formerly known as Healing Commercial…

3 months ago

Jaya Biosciences Presents Updated Preclinical Data in Alzheimer’s Disease at the 45th SIMD Annual Meeting

- Study results confirm potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s disease -SOUTH SAN FRANCISCO,…

3 months ago

ProPhase Labs Unveils Project ZenQ-AI

Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City,…

3 months ago

PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine

TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty…

3 months ago

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

Dr. Khan, formerly the Chief Data Science Officer and Global Head of Strategy and Portfolio, Innovative Medicine R&D at Johnson…

3 months ago